English
Specials
    Upgrade
    MoneycontrolBe a PRO
    Moneycontrol PRO
    you are here: HomeNewsBusinessEarnings

    PI Industries: A sizeable entry into pharma

    Acquisition of Ind Swift Laboratories would provide synergistic benefits and would be new growth catalyst for the company. Company believes the acquisition is the first step towards transforming itself into a more diversified player.

    Anubhav Sahu
    Bharat Gianani
    August 03, 2021 / 09:58 AM IST
    PI Industries: A sizeable entry into pharma

    PRO Only Highlights
    -      Quarterly performance largely backed by improved realisations
    -      Medium-term triggers China plus and protectionist measures for tyre industry
    -      Valuations not inexpensive; but improved medium-term outlook

    While PI Industries (PIND) (CMP: Rs 3,316, M Cap: Rs 50,347 crore) posted a sequentially flattish results, its foray into pharma has turned out to be a new catalyst for growth. PIND has entered into an agreement with Ind-Swift Laboratories Limited (ISLL) for acquiring its Active Pharmaceutical Ingredients (API) division for a cash consideration at an enterprise value (EV) of Rs 1,530 crore. Operational execution in API opportunity a key watch The API deal, at an EV/EBITDA of 7.7x, is apparently attractive,...

    • PRO Panorama

      Moneycontrol Pro Panorama | What a management change at TCS means for its investors

      Mar 17, 2023 / 04:01 PM IST

      In today’s edition of Moneycontrol Pro Panorama: India's growth challenge faces headwinds, no SVB-like situation for Indian bank...

      Read Now
    • PRO Weekender

      Moneycontrol Pro Weekender: Between the Fed and a hard place

      Mar 11, 2023 / 11:38 AM IST

      The Fed is caught between combating inflation and worries over a financial mishap

      Read Now

    To read the full story, Subscribe to Moneycontrol PRO

    Access the exclusive stories, weekly investment ideas and daily technical calls in an Ad free experience

    View Plans

    Already a member? Sign in

    Limited Period offer on Moneycontrol PRO. Subscribe to PRO and get up to

    50% OFF

    What Do You Get

    • Ad free experience

      Experience a non-intrusive navigation and faster response in the ad free mode

    • Sharpest Opinions

      Access to 230+ exclusive stories per month from our editorial and Experts

    • +

      Have a Global edge with access to content from world renowned experts and journalist

    • Actionable Insights

      Access to 40+ weekly investment ideas including 4 daily technical calls

    • Virtual Events

      Exclusive access to live webinars from market experts on trading and investment strategies

    • Newsletters

      Daily and weekly insights bundled and sent to your inbox to keep you ahead in the race.

    View Offers

    Get upto 50% discount on limited period offers